Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Aspen Pharmacare (APNHY)

Aspen Pharmacare (APNHY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 5,328,249
  • Shares Outstanding, K 446,252
  • Annual Sales, $ 2,296 M
  • Annual Income, $ 294,860 K
  • 60-Month Beta 1.23
  • Price/Sales 2.31
  • Price/Cash Flow 11.14
  • Price/Book 1.09
Trade APNHY with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings N/A on N/A
  • Latest Earnings Date 10/05/23
  • Annual Dividend & Yield 0.13 (1.06%)
  • Most Recent Dividend 0.126 on 09/21/23
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
10.9800 +8.74%
on 04/24/24
12.0000 -0.50%
on 04/30/24
+0.4400 (+3.83%)
since 03/21/24
3-Month
10.0100 +19.28%
on 02/12/24
12.0000 -0.50%
on 04/30/24
+1.4600 (+13.93%)
since 01/26/24
52-Week
8.3480 +43.03%
on 09/07/23
12.0000 -0.50%
on 04/30/24
+2.2075 (+22.68%)
since 04/25/23

Most Recent Stories

More News
New Strong Sell Stocks for July 11th

APNHY, AHCHY, and AMK have been added to the Zacks Rank #5 (Strong Sell) List on July 11, 2022.

AHCHY : 11.9100 (+3.03%)
APNHY : 11.9400 (+0.42%)
AMK : 34.00 (+0.18%)
New Strong Sell Stocks for March 22nd

APNHY,BRY, and CSIQ have been added to the Zacks Rank #5 (Strong Sell) List on March 22, 2022.

CSIQ : 16.07 (-1.71%)
BRY : 8.01 (-0.25%)
APNHY : 11.9400 (+0.42%)
New Strong Sell Stocks for February 28th

PRG, AGESY, and APNHY have been added to the Zacks Rank #5 (Strong Sell) List on February 28, 2022

AGESY : 46.0120 (-0.36%)
APNHY : 11.9400 (+0.42%)
PRG : 33.03 (-0.63%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy and ranks in the Top 1% of all short term signal directions.

Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Business Summary

Aspen Pharmacare Holdings Limited provide specialty, branded and generic pharmaceuticals for acute and chronic conditions. It operates primarily in Sub-Saharan Africa, Latin America, South East Asia and Eastern Europe. Aspen Pharmacare Holdings Limited is headquartered in Durban, South Africa.

See More

Key Turning Points

3rd Resistance Point 12.0400
2nd Resistance Point 12.0200
1st Resistance Point 11.9800
Last Price 11.9400
1st Support Level 11.9200
2nd Support Level 11.9000
3rd Support Level 11.8600

See More

52-Week High 12.0000
Last Price 11.9400
Fibonacci 61.8% 10.6049
Fibonacci 50% 10.1740
Fibonacci 38.2% 9.7431
52-Week Low 8.3480

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar